These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14392690)

  • 1. [The sensitivity determination of tubercle bacilli to antituberculous drugs. I. A simple method for pouring the antituberculous drugs into solid media].
    HIRASAWA I
    Kekkaku; 1955 Apr; 30(4):199-202; English summary, 213. PubMed ID: 14392690
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of antituberculous drugs on the morphology of tubercle bacilli studied by the slide culture method].
    HIROTANI F
    Kekkaku; 1958 May; 33(5):363-9; English abstract, 375. PubMed ID: 13550403
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synergistic effects of antituberculous agents on streptomycin resistant tubercle bacilli. 2. Synergistic effects in vivo of SM and other drugs on the SM (10r/cc) resistant tubercle bacilli].
    OKADA T
    Kekkaku; 1955 Feb; 30(2):72-80; English summary, 100. PubMed ID: 14382205
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic effects of antituberculous agents on streptomycin resistant tubercle bacilli. I. In vitro synergistic effects of antituberculous agents on the growth of tubercle bacilli with different degrees of resistance to streptomycin.
    OKADA T
    Kekkaku; 1954 Feb; 29(2):47-54. PubMed ID: 13164012
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of antituberculous drugs on the catalase-activities of sensitive and resistant strains of human type tubercle bacilli].
    NAKANO Y
    Kekkaku; 1956 Dec; 31(12):733-6. PubMed ID: 13406904
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in morphology & mode of development of tubercle bacilli & other Mycobacteria caused by antituberculous agents. V. Morphological studies on drug-resistant strains of Mycobacteria and the transformation of susceptible cells to resistant ones under the low levels of the drugs].
    ITO Y
    Kekkaku; 1958 Sep; 33(9):602-7; English abstract 646. PubMed ID: 13599181
    [No Abstract]   [Full Text] [Related]  

  • 7. A simple and safe method for determining the sensitivity of tubercle bacilli to antituberculous agents.
    McNAUGHT W
    J Clin Pathol; 1958 Mar; 11(2):190-1. PubMed ID: 13513799
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in morphology and mode of development of tubercle bacilli and other mycobacteria caused by antituberculous agents. II. The changes in the initial minute colonies of mycobacteria caused by isonicotinic acid hydrazide].
    ITO Y
    Kekkaku; 1958 Jun; 33(6):408-11; English abstract 445. PubMed ID: 13564623
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in morphology and mode of development of tubercle bacilli and other mycobacteria caused by antituberculous agents. III. The changes of the cells caused by SM or INH under various conditions, and the effect of SM and INH applied simultaneously or successively to the cells.
    ITO Y
    Kekkaku; 1958 Jul; 33(7):464-7; English abstract 518. PubMed ID: 13564631
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on the determination of the sensitivity of Koch bacilli to antibiotics; strains isolated from patients not subjected to previous treatment with antituberculous drugs].
    STEFANOPOULOS C; PAPAPANAGIOTOU J; RIGOPOULO H
    Rev Tuberc; 1957 Dec; 21(12):1423-6. PubMed ID: 13528547
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental studies on the synergic effect of antituberculous agents. I. In vitro synergic effect of some antituberculous agents on the growth of tubercle bacilli.
    MIZUNO M
    Kekkaku; 1952 Dec; 27(10):679-80. PubMed ID: 13045340
    [No Abstract]   [Full Text] [Related]  

  • 12. [The influence of antituberculous drugs upon intracellular tubercle bacilli].
    YOSHITAKE H
    Kekkaku; 1956 Apr; 31(4):228-33. PubMed ID: 13320646
    [No Abstract]   [Full Text] [Related]  

  • 13. [Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs].
    Sayğan MB; Ocak F; Cesur S; Tarhan G; Ceyhan I; Gümüişlü F; Beker G; Güner U; Coşkun E
    Mikrobiyol Bul; 2007 Jul; 41(3):403-9. PubMed ID: 17933251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some aspects of determination of the sensitivity of Mycobacterium tuberculosis to ethambutol using a semiliquid medium].
    Manicheva OA
    Probl Tuberk Bolezn Legk; 2003; (10):47-9. PubMed ID: 14669632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the homogeneous culture of tubercle bacilli and BCG strain. IV. The application of the shaking culture method for evaluation of inhibitory actions of antituberculous agents in vitro].
    MATSUO Y
    Kekkaku; 1952 Jun; 27(6):278-82. PubMed ID: 12991406
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological determination of activities of administered antituberculous drugs in the blood of animals.
    NAITO M; SHIODA A
    Acta Tuberc Jpn; 1954 Jun; 4(1):23-9. PubMed ID: 14361184
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis.
    Bapela NB; Lall N; Fourie PB; Franzblau SG; Van Rensburg CE
    Phytomedicine; 2006 Nov; 13(9-10):630-5. PubMed ID: 16987644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental studies on the effects of the combined use of antituberculous drugs by the slide cell culture method.
    MATSUSHIMA R
    Kekkaku; 1953 Dec; 28(11):793-7; concl; English abstract, 806. PubMed ID: 13143638
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of viability duration of Mycobacterium tuberculosis produced by subinhibitory concentrations of antituberculous drugs.
    TSUKAMURA M; NODA Y
    J Antibiot (Tokyo); 1958 Jul; 11(4):156-9. PubMed ID: 13587403
    [No Abstract]   [Full Text] [Related]  

  • 20. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.